25 Recruiting Advanced Melanoma Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Top Recruiting Advanced Melanoma Studies
Memory-Like Natural Killer Cells With Nivolumab and Relatlimab in Advanced or Metastatic Melanoma After Progression on Checkpoint Inhibitors
📍 Washington University School of Medicine — St Louis, Missouri
View Study & Checklist ➔FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
📍 University of Virginia — Charlottesville, Virginia
View Study & Checklist ➔Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
📍 Mayo Clinic Arizona — Phoenix, Arizona
View Study & Checklist ➔Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial
📍 Thomas Hospital — Fairhope, Alabama
View Study & Checklist ➔Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
View Study & Checklist ➔Naltrexone and Propranolol Combined With Immunotherapy
📍 Rutgers Cancer Institute of New Jersey — New Brunswick, New Jersey
View Study & Checklist ➔Talimogene Laherparepvec and Pembrolizumab in Treating Patients With Stage III-IV Melanoma
📍 University of South Alabama Mitchell Cancer Institute — Mobile, Alabama
View Study & Checklist ➔Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
📍 Ironwood Cancer & Research Centers — Chandler, Arizona
View Study & Checklist ➔VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
View Study & Checklist ➔A Study of Botensilimab (AGEN1181) for the Treatment of Advanced Melanoma
📍 Scottsdale Healthcare Hospitals DBA HonorHealth — Scottsdale, Arizona
View Study & Checklist ➔IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
📍 University of Arizona — Tucson, Arizona
View Study & Checklist ➔A Trial of Pembrolizumab and Metformin Versus Pembrolizumab Alone in Advanced Melanoma
📍 Univ of Pittsburgh Medical Center Hillman Cancer Center — Pittsburgh, Pennsylvania
View Study & Checklist ➔A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma
📍 Cedars-Sinai Medical Center — Los Angeles, California
View Study & Checklist ➔